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INTRODUCTION
Leriche syndrome, also referred to as aortoiliac occlusive
disease, results from thrombotic occlusion of the abdominal
aorta immediately above the site of its bifurcation (1). The
characteristic symptoms include intermittent bilateral clau-
dication with ischemic pain and absent or diminished
femoral pulses, along with pallor, coldness and fatigue of
both lower extremities, and inability to maintain penile
erection (1). Risk factors include hyperlipidemia, hyperten-
sion, diabetes mellitus, and smoking (2). Physical examina-
tion reveals weak or absent femoral and distal pulses.
Pathologically, the most common cause of Leriche syn-
drome has been found to be luminal narrowing of the
abdominal aorta and/or iliac arteries by atherosclerotic
obstruction (3).
The syndrome typically begins at the distal aorta or
common iliac artery origins and slowly progresses proxi-
mally and distally over time (4), rarely affecting the visceral
or renal arteries (5).
In this paper, we report a patient with Leriche syndrome
who suffered from bilateral renal artery occlusion-induced
resistant hypertension and could not be treated by revascu-
larization procedures or angiotensin-converting enzyme
(ACE) blockade. Eventually, maintenance hemodialysis
(HD) was initiated, with accompanying renin-angiotensin
blockers, to control the hypertension.
CASE DESCRIPTION
A 53-year-old male patient was admitted to the outpatient
clinic with a history of uncontrolled hypertension despite
antihypertensive treatment, consisting of diltiazem 120 mg
qd, amlodipine 10 mg qd, and doxazosin 4 mg qd. The
patient stated that he suffered from bilateral calf and
buttock claudications with a 100-m walk as well as erectile
dysfunction. He had been a heavy smoker (40 pack-years)
but never experienced angina. He did not suffer from
diabetes or hypercholesterolemia.
The patient’s brachial, radial, ulnar, and femoral pulses
were palpable bilaterally; however, his dorsalis pedis,
tibialis posterior and popliteal pulses were absent. There
was no evidence of atrophic or ischemic changes in the
lower extremities. Carotid bruits were heard on both sides
of the neck, and an audible bruit was noted over the left
renal artery. His blood pressure was 190/90 mmHg, and
grade-2 hypertensive retinopathy was found.
Blood chemistry analysis revealed a urea level of 108 mg/
dl and a creatinine level of 3.6 mg/dl; serum triglycerides,
cholesterol, glucose, HbA1c, and other biochemical para-
meters were within normal limits. The tests for AT III and
proteins C and S were negative. Ultrasonography revealed
that the right kidney was 95.6 mm, with a cortex width of
13.8 mm; the left kidney was 69.9 mm, with a cortex width
of 8.8 mm. The echogenicity was increased in both kidneys.
Color Doppler ultrasonography did not detect blood flow in
either renal artery. A 40-60% carotid stenosis was diagnosed
bilaterally. Doppler ultrasonography revealed high resis-
tance and normal triphasic waveforms in the bilateral
subclavian, axillary, brachial, radial and ulnar arteries.
Magnetic resonance angiography (MRA) revealed aortoiliac
occlusive disease (Leriche syndrome), concurrent with severe
bilateral stenosis of the renal and common iliac arteries. MRA
also demonstrated significant collateral circulation (Figure 1).
Tc99m DTPA perfusion scintigraphy revealed a delay in
the initiation of perfusion and a deterioration of function in
both kidneys, particularly in the left kidney (Figure 2).
A two-dimensional transthoracic echocardiography
revealed mild left atrial enlargement (LAd: 4.3 cm) and
concentric left ventricular hypertrophy.
Clinical course
The patient was hospitalized due to uncontrolled hyper-
tension. A balloon angioplasty and stenting procedure via
the axillary artery was attempted. However, the aortogra-
phy revealed complete occlusion of the abdominal aorta
immediately below the superior mesenteric artery (SMA),
and the renal arteries could not be observed (Figure 3). An
attempt to introduce the catheter into the renal arteries
using a 0.035 inch nitinol guide was unsuccessful; thus, the
procedure was terminated. By-pass grafting was discussed
with the patient, with an emphasis on the high risk of the
procedure and the potentially limited beneficial effects.
Valsartan (at a dosage of 80 mg/day) was added to the
current antihypertensive therapy. A very close follow-up
was indicated. A dramatic drop in blood pressure was
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observed the next day; however, the renal function continued
to deteriorate, with urea and creatinine levels escalating up to
298 and 8.5 mg/dl, respectively. The valsartan was with-
drawn, which resulted in a decrease in urea and creatinine
levels to 234 and 4.6 mg/dl, respectively. As soon as the
valsartan was stopped, the patient’s blood pressure again
increased up to 200/110 mmHg, despite conventional anti-
hypertensive treatment without ACE blockade.
Considering that ACE blockade improved the patient’s
uncontrolled hypertension but deteriorated kidney function,
the patient was enrolled in a maintenance hemodialysis
program. An ACE-inhibitor (ramipril 2.5 mg/day) was
initiated, which resulted in a dramatic improvement in
blood pressure. He was discharged in good clinical
condition with no subjective complaints and was placed
on a thrice-weekly hemodialysis regimen.
DISCUSSION
Leriche syndrome, which is characterized by the triad of
claudication, decreased pulses due to aortoiliac occlusion
and impotence, mostly occurs in men and is generally
diagnosed between 40 and 60 years of age (6,7). The
occlusion is usually due to atherosclerotic plaques in the
aorta with associated thrombi.
Because the progression of the disease is slow and collaterals
develop, limb-threatening ischemic disease does not tend to
occur (8). In our patient, because arterial perfusion of the lower
extremities was achieved via arterial collaterals, there were no
atrophic or ischemic changes in the lower extremities.
Leriche syndrome typically begins at the distal aorta or
common iliac artery origins and slowly progresses proximally
and distally over time. This progression is quite variable but
may ultimately extend to the level of the renal arteries or result
in complete aortic occlusion (4). Proximal propagation of an
occlusive distal aortic thrombus to the suprarenal level is rare (9).
Bergen and Trippel (10) suggested that aortic thrombosis may
progress to involve one or both renal arteries in 3-15% of patients
with distal aortic occlusion. As it progresses, the thrombosis may
gradually encroach upon a renal artery and cause increasingly
severe hypertension. The patient in this case had uncontrolled
blood pressure and bilateral renal artery occlusion, with an
occlusion of the abdominal aorta below the SMA.
MRA was indicated for imaging the renal vasculature;
however, the risk of nephrogenic systemic fibrosis was quite
high for this patient. The possible benefits and drawbacks
were first discussed extensively among the attending
doctors, and it was decided that the potential benefits
outweighed the risks. Afterward, the risks were discussed
with the patient, and only after having his verbal consent,
Figure 1 - Magnetic resonance angiography of the abdominal vessels, which reveals total occlusion of the abdominal aorta just below
superior mesenteric artery. The lower extremities and the abdomen are perfused by means of the collateral arteries.
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the MRA was performed using Dotarem (gadoterate
meglumine), which is least likely to cause nephrogenic
systemic fibrosis (11).
Revascularization of the renal arteries should be con-
sidered a radical treatment modality in all cases of renal
artery stenosis; renal angioplasty combined with stenting is
the preferred procedure (12-14). Because successful revas-
cularization via the brachial or axillary artery has been
reported in the literature (15-17), we attempted to place a
stent in the renal arteries bilaterally via the axillary artery;
however, the procedure was unsuccessful because the
catheter could not be introduced into the occluded segment.
Another option may be to place a by-pass graft between the
proximal and distal segments of the stenotic region.
However, this option was abandoned because the patient
did not give consent for the intervention when he was
informed about the risks of the operation.
At this time point, we were faced with the dilemma of
either leaving the patient with the risks of hypertension,
which was resistant to conventional antihypertensive
medications, or administering an ACE blockade medication,
despite the risks of acute kidney injury superimposed on
chronic renal failure. After discussing the options with the
patient, we decided to administer the angiotensin-II
receptor blocker valsartan at a dosage of 80 mg/day. His
blood pressure decreased rapidly to 110/70 mmHg; how-
ever, acute renal function deterioration superimposed on
chronic renal failure developed. This acute renal dysfunc-
tion could be due to nonspecific effects of hypotension,
Figure 2 - A Tc99m DTPA perfusion scintigraphy revealed a delay in the initiation of perfusion and deterioration of function for both
kidneys, affecting left kidney particularly.
Figure 3 - An AP view of the abdominal aorta by aortography.
The distal portion of the a. mesenterica superior (SMA) is
completely occluded. The proximal of the SMA, the coeliac
truncus and its branches can be seen clearly.
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which may have caused a sudden deterioration in kidney
perfusion. In contrast, the dysfunction may have been due
to ACE inhibition-related acute renal failure due to bilateral
renal artery stenosis. The incidence of significant azotemia
complicating ACE inhibition therapy in patients with
renovascular disease is uncertain. ACE inhibitor-induced
renal failure has been reported in 23% of patients with
bilateral renal artery stenosis and in 38% of patients with
only one kidney with a stenotic artery (18).
This problem is usually reversed by stopping the ACE
blockade, although some patients may suffer from perma-
nent renal failure. After stopping the valsartan, the previous
clinical/laboratory findings (i.e., hypertension and moder-
ately high levels of serum urea and creatinine) reversed. At
this time point, the initiation of maintenance hemodialysis
was inevitable. This strategy provided the opportunity to
control volume overload while also applying an ACE
blockade to satisfactorily control blood pressure.
This patient deserves special mention because the only
way to manage his condition was to initiate HD and
prescribe an ACE inhibitor. The patient was discharged
with well-controlled hypertension, but he would need
thrice-weekly HD for the rest of his life.
In conclusion, in patients with Leriche syndrome and
bilateral renal artery occlusion, hemodialysis accompanied
by antihypertensive therapy with a renin-angiotensin blocker
may be inevitable if renal revascularization is not an option.
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